Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	66988
Country	China

Received	2021-04-19 14:49
Peer-Review Started	2021-04-19 14:52
To Make the First Decision
Return for Revision	2021-06-14 06:36
Revised	2021-06-27 15:05
Second Decision	2021-12-02 03:26
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-12-03 06:57
Articles in Press	2021-12-03 06:57
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-11-26 00:48
Typeset the Manuscript	2021-12-16 10:11
Publish the Manuscript Online	2021-12-24 02:29

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Neoadjuvant treatment strategies for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Lei Xu, Lin Chen and Wei Zhang
ORCID	Author(s) ORCID Number Lei Xu http://orcid.org/0000-0001-9942-648X Lin Chen http://orcid.org/0000-0002-0190-7769 Wei Zhang http://orcid.org/0000-0002-3380-1010
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81860117
Corresponding Author	Wei Zhang, MD, Assistant Professor, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jie Fang Avenue, Wuhan 430030, Hubei Province, China. weizhangtjh@hust.edu.cn
Key Words	Hepatocellular carcinoma; Neoadjuvant therapy; Prognosis; Indications; Contraindications
Core Tip	Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. A considerable number of patients cannot receive radical therapy due to advanced HCC at the first diagnosis, leading to a poor prognosis. Neoadjuvant treatment enables more patients with HCC inside or outside the Milan criteria to receive surgical treatment, such as partial liver resection and liver transplantation. In this study, we reviewed the current status of neoadjuvant therapy in HCC.
Publish Date	2021-12-24 02:29
Citation	Xu L, Chen L, Zhang W. Neoadjuvant treatment strategies for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(12): 1550-1566
URL	https://www.wjgnet.com/1948-9366/full/v13/i12/1550.htm
DOI	https://dx.doi.org/10.4240/wjgs.v13.i12.1550

Full Article (PDF)	WJGS-13-1550.pdf
Full Article (Word)	WJGS-13-1550.docx
Manuscript File	66988_Auto_Edited-JLW-Filipodia.docx
Answering Reviewers	66988-Answering reviewers.pdf
Audio Core Tip	66988-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66988-Conflict-of-interest statement.pdf
Copyright License Agreement	66988-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	66988-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	66988-Language certificate.pdf
Peer-review Report	66988-Peer-review(s).pdf
Scientific Editor Work List	66988-Scientific editor work list.pdf
CrossCheck Report	66988-CrossCheck report.pdf